secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001096906-24-002072
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

Utah Medical Products appoints director Carrie Leigh, raises dividend 1.7% to $0.305
--------------------------------------------------------------------------------

- Board increased to 6 members; appointed Carrie Leigh, daughter of CEO Kevin Cornwell, effective Nov 1, 2024.
- Ms. Leigh worked at UTMD from 2004-2016, last as Global Direct End User Sales manager; now a consultant.
- She received 10,000 options at $64.09/share vesting over 4 years and quarterly board fee of $7,350.
- Quarterly cash dividend raised 1.7% to $0.305 per share, payable Jan 3, 2025 to holders of record Dec 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690624002072/0001096906-24-002072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690624002072/utmd-20241101.htm
  HTML page:      https://secwatch.observer/filing/0001096906-24-002072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer